NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report

Abstract Background Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a c...

Full description

Bibliographic Details
Main Authors: Kohei Arimizu, Gen Hirano, Chinatsu Makiyama, Mioko Matsuo, Takakazu Sasaguri, Akitaka Makiyama
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-5087-x
_version_ 1818947604878196736
author Kohei Arimizu
Gen Hirano
Chinatsu Makiyama
Mioko Matsuo
Takakazu Sasaguri
Akitaka Makiyama
author_facet Kohei Arimizu
Gen Hirano
Chinatsu Makiyama
Mioko Matsuo
Takakazu Sasaguri
Akitaka Makiyama
author_sort Kohei Arimizu
collection DOAJ
description Abstract Background Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors (ESFT). Case presentation A 49-year-old male presented with epistaxis and pain in the left eye. The patient had a tumor in the left nasal cavity at initial visit and it was biopsied. Firstly, the man was diagnosed with ESFT based on a histopathological examination. The tumor markedly responded to standard cytotoxic chemotherapy for ESFT with distant metastasis. After the start of therapy, a chromosomal analysis revealed an atypical translocation in ESFT and additional immunostaining was positive for anti-NUT antibody. Ultimately, the patient was definitively diagnosed with NC. He received multidisciplinary therapy and symptoms were temporarily relieved. However, he died 9 months after the diagnosis of NC. Conclusions When a pathologically undifferentiated tumor is evident along the midline of the body, NC must be included in the differential diagnosis, and immunohistochemical staining or genetic testing/chromosomal analysis needs to be performed.
first_indexed 2024-12-20T08:33:33Z
format Article
id doaj.art-9ea41379acb24410a0c3358836535cc7
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-20T08:33:33Z
publishDate 2018-11-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-9ea41379acb24410a0c3358836535cc72022-12-21T19:46:39ZengBMCBMC Cancer1471-24072018-11-011811610.1186/s12885-018-5087-xNUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case reportKohei Arimizu0Gen Hirano1Chinatsu Makiyama2Mioko Matsuo3Takakazu Sasaguri4Akitaka Makiyama5Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu HospitalDepartment of Hematology/Oncology, Japan Community Healthcare Organization Kyushu HospitalDepartment of Hematology/Oncology, Japan Community Healthcare Organization Kyushu HospitalDepartment of Head and neck surgery, Japan Community Healthcare Organization Kyushu HospitalDepartment of Pathology, Japan Community Healthcare Organization Kyushu HospitalDepartment of Hematology/Oncology, Japan Community Healthcare Organization Kyushu HospitalAbstract Background Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors (ESFT). Case presentation A 49-year-old male presented with epistaxis and pain in the left eye. The patient had a tumor in the left nasal cavity at initial visit and it was biopsied. Firstly, the man was diagnosed with ESFT based on a histopathological examination. The tumor markedly responded to standard cytotoxic chemotherapy for ESFT with distant metastasis. After the start of therapy, a chromosomal analysis revealed an atypical translocation in ESFT and additional immunostaining was positive for anti-NUT antibody. Ultimately, the patient was definitively diagnosed with NC. He received multidisciplinary therapy and symptoms were temporarily relieved. However, he died 9 months after the diagnosis of NC. Conclusions When a pathologically undifferentiated tumor is evident along the midline of the body, NC must be included in the differential diagnosis, and immunohistochemical staining or genetic testing/chromosomal analysis needs to be performed.http://link.springer.com/article/10.1186/s12885-018-5087-xNUT midline carcinomaEwing’s sarcoma family of tumors
spellingShingle Kohei Arimizu
Gen Hirano
Chinatsu Makiyama
Mioko Matsuo
Takakazu Sasaguri
Akitaka Makiyama
NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
BMC Cancer
NUT midline carcinoma
Ewing’s sarcoma family of tumors
title NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_full NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_fullStr NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_full_unstemmed NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_short NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report
title_sort nut carcinoma of the nasal cavity that responded to a chemotherapy regimen for ewing s sarcoma family of tumors a case report
topic NUT midline carcinoma
Ewing’s sarcoma family of tumors
url http://link.springer.com/article/10.1186/s12885-018-5087-x
work_keys_str_mv AT koheiarimizu nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT genhirano nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT chinatsumakiyama nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT miokomatsuo nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT takakazusasaguri nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport
AT akitakamakiyama nutcarcinomaofthenasalcavitythatrespondedtoachemotherapyregimenforewingssarcomafamilyoftumorsacasereport